Objective: To conduct the first support vector machine (SVM)-based study comparing the diagnostic accuracy of T1-weighted magnetic resonance imaging (T1-MRI), F-fluorodeoxyglucose-positron emission tomography (FDG-PET) and regional cerebral blood flow single-photon emission computed tomography (rCBF-SPECT) in Alzheimer’s disease (AD). Method: Brain T1-MRI, FDG-PET and rCBF-SPECT scans were acquired from a sample of mild AD patients (n=20) and healthy elderly controls (n=18). SVM-based diagnostic accuracy indices were calculated using whole-brain information and leave-one-out cross-validation. Results: The accuracy obtained using PET and SPECT data were similar. PET accuracy was 68∼71% and area under curve (AUC) 0.77∼0.81; SPECT accuracy was 68∼74% and AUC 0.75∼0.79, and both had better performance than analysis with T1-MRI data (accuracy of 58%, AUC 0.67). The addition of PET or SPECT to MRI produced higher accuracy indices (68∼74%; AUC: 0.74∼0.82) than T1-MRI alone, but these were not clearly superior to the isolated neurofunctional modalities. Conclusion: In line with previous evidence, FDG-PET and rCBF-SPECT more accurately identified patients with AD than T1-MRI, and the addition of either PET or SPECT to T1-MRI data yielded increased accuracy. The comparable SPECT and PET performances, directly demonstrated for the first time in the present study, support the view that rCBF-SPECT still has a role to play in AD diagnosis.

INTRODUÇÃO: A doença de Graves (DG) é a causa mais comum de hipertireoidismo e, entre as abordagens terapêuticas mais utilizadas para o tratamento do hipertireoidismo por doença de Graves, encontram-se a cirurgia, o uso de drogas antitireoidianas e a radioiodoterapia. No cálculo dosimétrico para determinação da dose de radioiodo a ser utilizada, é possível empregar a ultrassonografia e a cintilografia para avaliar o volume tireoidiano. OBJETIVO: O presente estudo visa correlacionar essas metodologias com ênfase no volume obtido e nas implicações dosimétricas. SUJEITOS E MÉTODOS: Foram incluídos no estudo 103 pacientes com diagnóstico de DG encaminhados para radioiodoterapia. Esses foram submetidos à ultrassonografia da tireoide e à cintilografia tireoidiana, com cálculo de volume pela cintilografia baseado na fórmula de Allen. RESULTADOS E CONCLUSÕES: Observou-se boa correlação entre os dois métodos, porém com massa estimada pela cintilografia sistematicamente maior que a estimada pela ultrassonografia, o que pode acarretar em menor estimativa de dose absorvida quando utilizado o método cintilográfico.

INTRODUCTION: Graves disease (GD) is the most common cause of hiperthyroidism, and the most common treatment options are surgery, antithyroid drugs and radioiodine therapy. In radiodosimetric calculations to determine radioiodine dosage it is possible to use thyroid volume estimatives based on ultrasound or scintigraphy. OBJECTIVE: The present study aimed to correlate these methodologies emphasizing volume estimatives and dosimetric implications. SUBJECTS AND METHODS: Were included 103 patients with GD diagnosis and indication of radioiodine treatment. They were submitted to thyroid ultrasound and thyroid scintigraphy. RESULTS AND CONCLUSIONS: Good correlation between both methods was observed, although scintigraphy systematically obtained greater volumes than ultrasound implying in lower estimatives of absorbed dose when scintigraphy is used.